Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Biochemical Bone Marker Immunoassay

By HospiMedica staff writers
Posted on 13 Feb 2001
A patented new immunoassay measures the breakdown of collagen in a urine sample. More...
The test is intended for use by researchers seeking to characterize the degradation of bone tissue that occurs in osteoporosis and related diseases and in detecting the effects of therapies that halt such destruction.

Osteoporosis is characterized by decreased mass and quality of bone tissue, increased turnover, and a corresponding increased risk for bone fracture. Type I collagen is degraded more quickly than it is produced and incorporated into new bone. The degradation fragments of collagen appear in the blood and urine of patients where they can be detected by sensitive and specific immunoassays. The new immunoassay, called the Metra Helical Peptide immunoassay, is the product of Quidel Corp. (San Diego, CA, USA).

"We anticipate that Metra Helical Peptide will be a valuable research tool for detecting excessive bone deterioration and for assessing the effects of bone-active therapies,” said S. Wayne Kay, president and CEO of Quidel.



Related Links:
Quidel

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.